133 related articles for article (PubMed ID: 20397370)
1. Commentary on: L-methylfolate, methylcobolamine, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline.
Cummings JL
CNS Spectr; 2010 Jan; 15(1 Suppl 1):7. PubMed ID: 20397370
[No Abstract] [Full Text] [Related]
2. L-methylfolate, methylcobalamin, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline.
McCaddon A; Hudson PR
CNS Spectr; 2010 Jan; 15(1 Suppl 1):2-5; discussion 6. PubMed ID: 20397369
[TBL] [Abstract][Full Text] [Related]
3. Complementary and alternative treatments for autism part 1: evidence-supported treatments.
Bent S; Hendren RL
AMA J Ethics; 2015 Apr; 17(4):369-74. PubMed ID: 25901707
[No Abstract] [Full Text] [Related]
4. Efficacy of Vitamin B Supplementation on Cognition in Elderly Patients With Cognitive-Related Diseases.
Zhang DM; Ye JX; Mu JS; Cui XP
J Geriatr Psychiatry Neurol; 2017 Jan; 30(1):50-59. PubMed ID: 28248558
[TBL] [Abstract][Full Text] [Related]
5. Lipid lowering agents to delay cognitive decline in Alzheimer's disease?
de Leeuw FE
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1611-3. PubMed ID: 16291879
[No Abstract] [Full Text] [Related]
6. CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease.
Shankle WR; Hara J; Barrentine LW; Curole MV
J Alzheimers Dis; 2016 Oct; 54(3):1073-1084. PubMed ID: 27567825
[TBL] [Abstract][Full Text] [Related]
7. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease.
Simpkins JW; Singh M; Bishop J
Neurobiol Aging; 1994; 15 Suppl 2():S195-7. PubMed ID: 7700453
[No Abstract] [Full Text] [Related]
8. Tacrine approved for cognitive deficits in Alzheimer's disease.
Nurse Pract; 1994 Jan; 19(1):6-8. PubMed ID: 8139805
[No Abstract] [Full Text] [Related]
9. Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model.
Hsiao YH; Kuo JR; Chen SH; Gean PW
Neurobiol Dis; 2012 Mar; 45(3):1111-20. PubMed ID: 22227002
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine in trichotillomania: a panacea for compulsive skin disorders?
Taylor M; Bhagwandas K
Br J Dermatol; 2014 Nov; 171(5):1253-5. PubMed ID: 24773206
[No Abstract] [Full Text] [Related]
11. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.
Masse I; Bordet R; Deplanque D; Al Khedr A; Richard F; Libersa C; Pasquier F
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1624-9. PubMed ID: 16291883
[TBL] [Abstract][Full Text] [Related]
12. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
13. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
Strnad J; Bahro M
Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
[No Abstract] [Full Text] [Related]
14. N-acetylcysteine for cholesteatoma?
Altschuler EL
J Otolaryngol; 2001 Feb; 30(1):67. PubMed ID: 11770980
[No Abstract] [Full Text] [Related]
15. Treatment strategies for the cognitive deficits of Alzheimer's disease.
Meador KJ
J S C Med Assoc; 1994 Nov; 90(11):543-7. PubMed ID: 7853858
[No Abstract] [Full Text] [Related]
16. N-acetylcysteine in trichotillomania: further thoughts.
Goulding JMR
Br J Dermatol; 2015 Jun; 172(6):1683-1684. PubMed ID: 25640599
[No Abstract] [Full Text] [Related]
17. Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease.
Adair JC; Knoefel JE; Morgan N
Neurology; 2001 Oct; 57(8):1515-7. PubMed ID: 11673605
[TBL] [Abstract][Full Text] [Related]
18. Renal protection by N-acetylcysteine.
Shehabi Y
Br J Anaesth; 2007 Feb; 98(2):270; author reply 270-1. PubMed ID: 17251216
[No Abstract] [Full Text] [Related]
19. Toxic epidermal necrolysis treated with N-acetylcysteine.
Vélez A; Moreno JC
J Am Acad Dermatol; 2002 Mar; 46(3):469-70. PubMed ID: 11862195
[No Abstract] [Full Text] [Related]
20. Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
Remington R; Bechtel C; Larsen D; Samar A; Page R; Morrell C; Shea TB
J Alzheimers Dis; 2016; 51(4):991-5. PubMed ID: 26967219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
